Gene Therapy for Head and Neck Squamous Cell Carcinoma Using KITENIN (KAI1 COOH-Terminal Interacting Tetraspanin)-Antisense Therapy.
10.3349/ymj.2011.52.3.463
- Author:
Joon Kyoo LEE
1
;
Dong Hoon LEE
;
Eun Gene SUN
;
Jeong A BAE
;
Sang Chul LIM
;
Jeong Joon MIN
;
Myung Whun SUNG
;
Kyung Keun KIM
Author Information
1. Department of Otolaryngology-Head and Neck Surgery, Chonnam National University Medical School, Hwasun Hospital, Hwasun, Korea. joonkyoo@chonnam.ac.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Gene therapy;
head and neck cancer;
squamous cell carcinoma;
KITENIN protein;
small interfering RNA (siRNA)
- MeSH:
Carcinoma, Squamous Cell/genetics/pathology/*therapy;
Carrier Proteins/*antagonists & inhibitors/genetics;
Cell Line, Tumor;
Cell Movement;
Cell Proliferation;
*Gene Therapy;
Head and Neck Neoplasms/genetics/pathology/*therapy;
Humans;
Membrane Proteins/*antagonists & inhibitors/genetics;
*RNA, Small Interfering
- From:Yonsei Medical Journal
2011;52(3):463-468
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: KAI1 COOH-terminal interacting tetraspanin (KITENIN) has been found to act as a promoter of metastasis in murine models of colon cancer and squamous cell carcinoma (SCC). The suppression of tumor progression and metastasis of established colon cancer in mice was observed after intravenous delivery of small interfering RNA (siRNA) targeting KITENIN. The purpose of this study was to investigate the efficacy of gene therapy targeting KITENIN in human head and neck SCC. MATERIALS AND METHODS: SNU-1041, a well-established human hypopharyngeal SCC cell line, was used. KITENIN expression in SNU-1041 was measured by Western blot analysis. The cells were prepared, maintained in culture dishes with media, and divided into two groups: the si-KITENIN group and the scrambled group (control). The siRNA targeting KITENIN (si-KITENIN) and scrambled DNA were transfected into the SNU-1041 cells in each group. The effect of gene therapy was compared by in vitro experiments to evaluate invasion, migration, and proliferation. RESULTS: KITENIN was strongly expressed in the SNU-1041 cells, and the number of invaded cells was reduced more in the si-KITENIN group than in the scrambled group (p<0.001). The speed for the narrowing gap, made through adherent cells, was lower in the si-KITENIN group (p<0.001), and the number of viable proliferating cells was reduced in the si-KITENIN group compared to the scrambled group (p<0.001, the third day). KITENIN protein expression was no longer identified in the si-KITENIN group. CONCLUSION: Gene therapy using an anti-KITENIN strategy might be effective for head and neck squamous carcinoma.
